In 2023, China's dominance in the global export of tetracyclines grew by 2.06%, reinforcing its leadership. Belgium and Italy showed robust increases of 5.52% and 1.33%, respectively, highlighting their growing market share. Meanwhile, Ireland and Canada experienced notable declines of -4.17% and -5.63%. Switzerland and Israel exhibited significant growth, with increases of 16.32% and 21.74%. On the contrary, Germany and Austria saw sharp declines of -12.44% and -20.56%. The average compound annual growth rate over the past five years presents China, Belgium, and Italy as dominant players, steadily expanding their influence in the market.
Future trends to watch include potential market shifts due to geopolitical tensions and regulatory changes in pharmaceuticals. Emerging markets may start to play a more significant role, potentially altering the existing landscape. Additionally, technological advancements and innovations in drug synthesis could impact production efficiency and competitive dynamics among exporting countries.
Top countries in Export of Tetracyclines Share by Country (US Dollars)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 56 | 2023 | +2.35% | +2.06% | View data |
| 2 | 2 Belgium | 14.23 | 2023 | +0.86% | +5.52% | View data |
| 3 | 3 Italy | 10.77 | 2023 | +2.21% | +1.33% | View data |
| 4 | 4 Portugal | 7.36 | 2023 | +2.5% | +0.99% | View data |
| 5 | 5 Ireland | 6.12 | 2023 | -11.46% | -4.17% | View data |
| 6 | 6 South Korea | 3.88 | 2023 | +4.56% | +5.06% | View data |
| 7 | 7 Netherlands | 1.53 | 2023 | -1.97% | -3.44% | View data |
| 8 | 8 Switzerland | 1.25 | 2023 | +4.98% | +16.32% | View data |
| 9 | 9 United States | 0.94 | 2023 | -1.49% | -2.36% | View data |
| 10 | 10 Spain | 0.75 | 2023 | +1.81% | -0.95% | View data |
